<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biol Reprod</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Reprod</journal-id>
<journal-id journal-id-type="publisher-id">biolreprod</journal-id>
<journal-title-group>
<journal-title>Biology of Reproduction</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3363</issn>
<issn pub-type="epub">1529-7268</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30927408</article-id>
<article-id pub-id-type="pmc">6561861</article-id>
<article-id pub-id-type="doi">10.1093/biolre/ioz048</article-id>
<article-id pub-id-type="publisher-id">ioz048</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dexamethasone induces primary amnion epithelial cell senescence through telomere-P21 associated pathway<sup><xref ref-type="fn" rid="fn1a">†</xref></sup></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Laura F</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-8392-2833</contrib-id>
<name>
<surname>Richardson</surname>
<given-names>Lauren S</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-4663-7926</contrib-id>
<name>
<surname>da Silva</surname>
<given-names>Márcia Guimarães</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-3991-1747</contrib-id>
<name>
<surname>Sheller-Miller</surname>
<given-names>Samantha</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-9213-6105</contrib-id>
<name>
<surname>Menon</surname>
<given-names>Ramkumar</given-names>
</name>
<!--<email>ram.menon@utmb.edu</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Obstetrics &amp; Gynecology, Division of Maternal-Fetal Medicine &amp; Perinatal Research, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA</aff>
<aff id="aff2"><label>2</label>Department of Pathology, Botucatu Medical School, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil</aff>
<aff id="aff3"><label>3</label>Department of Neuroscience, Cell Biology &amp; Anatomy, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA</aff>
<author-notes>
<corresp id="cor1"><bold>Correspondence:</bold> Department of Obstetrics and Gynecology, 11.138 Medical Research Building, The University of Texas Medical Branch at Galveston, Galveston, TX 77555-0111, USA. Tel: +409-772-7596; E-mail: <email>ram.menon@utmb.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-03-30" pub-type="epub">
<day>30</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>100</volume>
<issue>6</issue>
<fpage>1605</fpage>
<lpage>1616</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>30</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019. Published by Oxford University Press on behalf of Society for the Study of Reproduction.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="ioz048.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Dexamethasone (Dex), a corticosteroid hormone, is used during the perinatal period to help fetal lung and other organ development. Conversely, Dex-induced cell proliferation has been associated with accelerated aging. Using primary amnion epithelial cells (AECs) from term, not in labor, fetal membranes, we tested the effects of Dex on cell proliferation, senescence, and inflammation. Primary AECs treated with Dex (100 and 200 nM) for 48 h were tested for cell viability (crystal violet dye exclusion), cell cycle progression and/or type of cell death (flow cytometry), expression patterns of steroid receptors (glucocorticoid receptor, progesterone receptor membrane component 1&amp;2), inflammatory mediators (IL-6 and IL-8), and telomere length (quantitative RT-PCR). Mechanistic mediators of senescence (p38MAPK and p21) were determined by western blot analysis. Dex treatment did not induce AEC proliferation, cell cycle, influence viability, or morphology. However, Dex caused dependent telomere length reduction and p38MAPK-independent but p21-dependent (confirmed by treatment with p21 inhibitor UC2288). Senescence was not associated with an increase in inflammatory mediators, which is often associated with senescence. Co-treatment with RU486 produced DNA damage, cell cycle arrest, and cellular necrosis with an increase in inflammatory mediators. The effect of Dex was devoid of changes to steroid receptors, whereas RU486 increased GR expression. Dex treatment of AECs produced nonreplicative and noninflammatory senescence. Extensive use of Dex during the perinatal period may lead to cellular senescence, contributing to cellular aging associated pathologies during the perinatal and neonatal periods.</p>
</abstract>
<abstract abstract-type="teaser">
<p>Dexamethasone induces telomere-dependent p21 mediated non-replicated and non-inflammatory senescence in fetal amnion epithelial cells.</p>
</abstract>
<kwd-group kwd-group-type="keywords">
<kwd>steroids</kwd>
<kwd>preterm birth</kwd>
<kwd>lung maturity</kwd>
<kwd>aging</kwd>
<kwd>RU486</kwd>
<kwd>inflammation</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Environmental Toxicology Training Program</named-content>
</funding-source>
<award-id>T32ES007254</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Environmental Health Sciences</named-content>
<named-content content-type="funder-identifier">10.13039/100000066</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NICHD</named-content>
<named-content content-type="funder-identifier">10.13039/100000071</named-content>
</funding-source>
<award-id>1R01HD084532-01A1</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="12"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>